Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Makoto Tsuji"'
Autor:
Makoto Tsuji, Masafumi Nii, Marie Furuta, Shinji Baba, Takahide Maenaka, Shigetaka Matsunaga, Hiroaki Tanaka, Atsushi Sakurai, on behalf of the Japan Resuscitation Council (JRC) of the Guideline Editorial Committee
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Local anaesthetic systemic toxicity (LAST) is a rare but life-threatening complication that can occur after local anaesthetic administration. Various clinical guidelines recommend an intravenous lipid emulsion as a treatment for l
Externí odkaz:
https://doaj.org/article/dd6d494c979e4617ba9aa6aa98f5c942
Autor:
Shintaro Maki, Sho Takakura, Makoto Tsuji, Shoichi Magawa, Yuya Tamaishi, Masafumi Nii, Michiko Kaneda, Kenta Yoshida, Kuniaki Toriyabe, Eiji Kondo, Tomoaki Ikeda
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 804 (2024)
Fetal growth restriction (FGR) is a major concern in perinatal care. Various medications have been proposed as potential treatments for this serious condition. Nonetheless, there is still no definitive treatment. We studied tadalafil, a phosphodieste
Externí odkaz:
https://doaj.org/article/97f12b13eb44417497d28c193c2c40a0
Autor:
Makoto Tsuji, Shintaro Maki, Naosuke Enomoto, Kota Okamoto, Asa Kitamura, Shoichi Magawa, Sho Takakura, Masafumi Nii, Kayo Tanaka, Noriko Yodoya, Hiroaki Tanaka, Hirofumi Sawada, Eiji Kondo, Masahiro Hirayama, Tomoaki Ikeda
Publikováno v:
Medicina, Vol 59, Iss 5, p 900 (2023)
Background and Objectives: Tadalafil is expected to treat fetal growth restriction (FGR), a risk factor for stillbirth and neonatal morbidity. This study aimed to evaluate the fetal biometric growth pattern of fetuses with FGR treated with tadalafil
Externí odkaz:
https://doaj.org/article/1fda1711e6294b7a978d6a1a35cf3f0d
Autor:
Mizuha Odagami, Akiko Iwata, Kazumi Kubota, Kentaro Kurasawa, Mika Okuda, Shigeru Aoki, Tomoo Hirabuki, Tomoko Tujie, Haruya Saji, Tetsuya Hasegawa, Natsuko Kobayashi, Yutaka Ueda, Shinichi Ishioka, Takayuki Enomoto, Makoto Tsuji, Hiroyuki Shigeta, Kumi Koike, Hiroaki Tanaka, Rie Tsukinaga, Yoshimi Hasegawa, Reiko Numazaki, Hajime Ota, Hiroaki Kase, Hiroshi Ishikawa, Yoshihiro Saito, Takaharu Yamawaki, Etsuko Miyagi
Publikováno v:
Maternal and Child Health Journal. 27:933-943
Objectives We aimed to clarify the accuracy of pregnant women’s knowledge and understanding regarding infectious disease screening in early pregnancy and clarify the roles that should be played by health care providers in promoting the health of pr
Autor:
Hiroaki Tanaka, Shigetaka Matsunaga, Marie Furuta, Rie Kato, Shinji Takahashi, Jun Takeda, Masahiro Nakao, Eishin Nakamura, Masafumi Nii, Tomoyuki Yamashita, Yoshihiro Yamahata, Naosuke Enomoto, Makoto Tsuji, Shiniji Baba, Yuki Hosokawa, Takahide Maenaka, Atsushi Sakurai
Publikováno v:
The journal of obstetrics and gynaecology researchReferences.
The perinatal resuscitation history in Japan is short, with the earliest efforts in the field of neonatology. In contrast, the standardization and dissemination of maternal resuscitation is lagging. With the establishment of the Maternal Death Report
Autor:
Michiko Kaneda, Shintaro Maki, Tomomi Kotani, Hiroaki Tanaka, Toru Ogura, Tadashi Kimura, Masafumi Nii, Fumi Furuhashi, Kayo Tanaka, Shoichi Magawa, Makoto Tsuji, Akihiko Sekizawa, Tomoaki Ikeda, Masayuki Endoh, Yuki Nishimura
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 34:3709-3715
To evaluate the effectiveness and safety of tadalafil treatment for hypertensive disorder of pregnancy (HDP).In an open-label, randomized clinical trial, singleton pregnancies with HDP between 20 and 33 weeks of gestation were randomized to take 20 m
Autor:
Kenji Ikemura, Tadashi Kimura, Takashi Umekawa, Tomoaki Ikeda, Yuki Kamimoto, Kayo Tanaka, Hiroaki Tanaka, Masafumi Nii, Eiji Kondo, Masahiro Okuda, Masayuki Endoh, Ineko Kato, Ryota Tachibana, Ning Ma, Michiko Kaneda, Hiroshi Hosoda, Shintaro Maki, Shoichi Magawa, Kento Yoshikawa, Fumi Furuhashi, Takao Owa, Makoto Tsuji, Kyoko Shimada, Takekazu Miyoshi
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
We have demonstrated that tadalafil facilitates fetal growth in mice with L-NG-nitroarginine methyl ester (L-NAME)-induced preeclampsia (PE) with fetal growth restriction (FGR). Tadalafil is a selective phosphodiesterase 5 inhibitor that dilates the
Autor:
Kazuhiko Mori, Makoto Shirai, Makoto Tsuji, Sanae Takada, Jun Hirao, Takayoshi Nishiya, Wataru Saitoh, Takuma Iguchi
Publikováno v:
Toxicology Letters. 295:416-423
Plasma citrulline is decreased in cases of severe intestinal injury with apparent villus and cellular atrophy. However, the fluctuation of plasma citrulline in slight intestinal injury remains to be investigated. To clarify this, irinotecan at 30 mg/
Publikováno v:
Journal of the Japan Veterinary Medical Association. 70:523-528
Autor:
Fumi Furuhashi, Yuki Nishimura, Shintaro Maki, Tadashi Kimura, Masayuki Endoh, Makoto Tsuji, Hiroaki Tanaka, Shoichi Magawa, Akihiko Sekizawa, Satoshi Tamaru, Masafumi Nii, Toru Ogura, Eiji Kondo, Kayo Tanaka, Michiko Kaneda, Tomomi Kotani, Tomoaki Ikeda
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 6
Journal of Clinical Medicine, Vol 8, Iss 6, p 856 (2019)
Volume 8
Issue 6
Journal of Clinical Medicine, Vol 8, Iss 6, p 856 (2019)
Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor with a long half-life, high selectivity, and rapid onset of action. Because the safety of using PDE5 inhibitors as therapeutic agents for fetal growth restriction (FGR) has been a problem worldwide,